Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App
Posted
Frank Vinluan (via MedCity News)
Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.
The post Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App appeared first on MedCity News.